Literature DB >> 26362237

1st metatarsophalangeal joint fusion: A comparison of non-union and gender differences between locking and non-locking plating systems.

Edward James Bass1, Siva Prasad Sirikonda2.   

Abstract

BACKGROUND: Fusion of the first metatarsophalangeal joint (1st MTPJ) is a common surgical procedure used to treat a variety of diseases and deformities of the forefoot. Fixation methods vary and typically fusion rates are good.
OBJECTIVES: The objectives of the study are to demonstrate whether there is any advantage to using locking as opposed to non-locking plates for 1st MTPJ fusion. Additionally the study aims to determine whether there is any difference in non-union rates according to gender.
METHODS: One hundred and seventy two consecutive 1st MTPJ fusions were performed for 153 patients. 40 patients (23%) were male and 132 (77%) female. Twenty patients received Hallu-fix™ plates, 76 Charlotte™ plates and 76 Anchorage™ plates. Postoperative radiographs were reviewed for non-union. Failure rates were compared using Fisher's exact tests (p=0.05).
RESULTS: Twelve (6.9%) non-unions were identified. The difference in failure rates between all systems was not statistically significant. However, the difference in fusion rates between males (17.5%) and females (3.8%) was significant.
CONCLUSION: This study finds that 1st MTPJ fusion is an effective method to treat diseases of the 1st MTPJ. Locking plates may offer better fusion rates than their non-locking counterparts. This is especially evident in male patients.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  First; Fusion; Joint; Locking; Metatarsophalangeal; Non-locking

Mesh:

Year:  2015        PMID: 26362237     DOI: 10.1016/j.foot.2015.07.011

Source DB:  PubMed          Journal:  Foot (Edinb)        ISSN: 0958-2592


  1 in total

Review 1.  First metatarsophalangeal joint arthrodesis/fusion: a systematic review of modern fixation techniques.

Authors:  Yang S Kang; Andy Bridgen
Journal:  J Foot Ankle Res       Date:  2022-04-26       Impact factor: 3.050

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.